Substance / Medication

Amcinonide

Overview

Active Ingredient
amcinonide
RxNorm CUI
17652

Indications

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Labeler: Solubiomix, LLCUpdated: 2025-12-10T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment.
Heidari Nazila, Ghannadzadeh Kermani Pour Rad, Farshbafnadi Melina et al. · Orphanet J Rare Dis · 2025
PMID: 40383754Meta-AnalysisFull text (PMC)
Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis.
Zhang Lu, Su Yaoxi, Shucheng Huidi et al. · J Am Acad Dermatol · 2024
PMID: 37977294Meta-Analysis
Prevalence and associated factors of head lice infestation among primary school children in low- and middle-income countries: systematic review and meta-analysis.
Delie Amare Mebrat, Melese Mihret, Limenh Liknaw Workie et al. · BMC Public Health · 2024
PMID: 39135177Meta-AnalysisFull text (PMC)
In Vivo Imaging Techniques for the Human Scalp: A Systematic Review of the Literature.
Hedayati Bobak, Horton Luke, Urso Brittany et al. · Lasers Surg Med · 2024
PMID: 39327816Meta-Analysis
Establishing baselines of hair density measurements: Variations across ethnicity, scalp region, and measurement techniques: A systematic review.
Buontempo Michael G, Sperling Leonard C, Alhanshali Lina et al. · J Am Acad Dermatol · 2023
PMID: 37604232Meta-Analysis
Diagnostic Accuracy of Trichoscopy in Inflammatory Scalp Diseases: A Systematic Review.
Golińska Joanna, Sar-Pomian Marta, Rudnicka Lidia · Dermatology · 2022
PMID: 34265772Meta-Analysis
Prevalence of Pediculosis Among Primary School-Aged Students in Iran: an Updated Comprehensive Systematic Review and Meta-Analysis.
Akbari Morteza, Sheikhi Soraya, Rafinejad Javad et al. · J Med Entomol · 2022
PMID: 36166587Meta-Analysis
Approach to treatment of refractory dissecting cellulitis of the scalp: a systematic review.
Thomas Jamael, Aguh Crystal · J Dermatolog Treat · 2021
PMID: 31348693Meta-Analysis
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review.
Camela Elisa, Ocampo-Garza Sonia Sofía, Cinelli Eleonora et al. · Dermatol Ther · 2021
PMID: 33559275Meta-Analysis
Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing.
Sasseville D · Contact Dermatitis · 2001
PMID: 11683835Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Amcinonide (substance)
SNOMED CT
67980007
UMLS CUI
C0051556
RxNorm CUI
17652
Labeler
Solubiomix, LLC

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.